Evidence map›Paper›PMID 30062726›Full record

ReviewCell proliferation2018

Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.

Melis Çolakoğlu, Sinem Tunçer, Sreeparna Banerjee

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell proliferation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 71 citations in OpenAlex.

  1. Allosteric properties of mammalian ALOX15 orthologs.The Journal of biological chemistry · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Ferroptosis is an effective strategy for cancer therapy.Medical oncology (Northwood, London, England) · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Melis ÇolakoğluDepartment of Biological Sciences, Middle East Technical University, Ankara, Turkey.
Sinem TunçerDepartment of Biological Sciences, Middle East Technical University, Ankara, Turkey.
Sreeparna BanerjeeDepartment of Biological Sciences, Middle East Technical University, Ankara, Turkey.ORCID http://orcid.org/0000-0003-4596-6768
Middle East Technical University · TR

Funding

BAGEPTÜBİTAK 111S308TÜBİTAK 113S063TÜBİTAK 113S935
6 · The paper itself

Abstract

The oxygenation of polyunsaturated fatty acids such as arachidonic and linoleic acid through lipoxygenases (LOXs) and cyclooxygenases (COXs) leads to the production of bioactive lipids that are important both in the induction of acute inflammation and its resolution. Amongst the several isoforms of LOX that are expressed in mammals, 15-LOX-1 was shown to be important both in the context of inflammation, being expressed in cells of the immune system, and in epithelial cells where the enzyme has been shown to crosstalk with a number of important signalling pathways. This review looks into the latest developments in understanding the role of 15-LOX-1 in different disease states with emphasis on the emerging role of the enzyme in the tumour microenvironment as well as a newly re-discovered form of cell death called ferroptosis. We also discuss future perspectives on the feasibility of use of this protein as a target for therapeutic interventions.

Indexed as

AnimalsArachidonate 15-LipoxygenaseCell DeathHumansLipid MetabolismSignal TransductionTumor MicroenvironmentArachidonate 15-Lipoxygenase15-LOX-1cancerferroptosisinflammationtumour microenvironment

Identifiers

PMID30062726
PMCPMC6528901
OpenAlexW2886317149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.